We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.3B
AUM Growth
+$247M
Cap. Flow
+$141M
Cap. Flow %
6.12%
Top 10 Hldgs %
17.75%
Holding
321
New
26
Increased
135
Reduced
107
Closed
32

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$27M
2
REVG
REV Group
REVG
+$18.6M
3
DBD
Diebold Nixdorf Incorporated
DBD
+$17.2M
4
WGO icon
Winnebago Industries
WGO
+$10.7M
5
SUPN icon
Supernus Pharmaceuticals
SUPN
+$9.54M

Top Sells

Rank Stock Value
1
CEB
CEB Inc.
CEB
+$22.7M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$20.1M
3
HELE icon
Helen of Troy
HELE
+$20M
4
ALOG
Analogic Corp
ALOG
+$18.5M
5
AMRI
Albany Molecular Research Inc
AMRI
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 20.64%
2 Technology 18.67%
3 Industrials 18.25%
4 Consumer Discretionary 13.65%
5 Financials 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
1
Supernus Pharmaceuticals
SUPN
$2.6B
$58.7M 2.55%
1,361,373
+267,971
+25% +$9.54M
TTEK icon
2
Tetra Tech
TTEK
$8.35B
$57.5M 2.5%
6,280,905
+673,850
+12% +$6M
STMP
3
DELISTED
Stamps.com, Inc.
STMP
$48.3M 2.1%
312,063
+51,346
+20% +$6.47M
CRTO icon
4
Criteo S.A. Ordinary Shares
CRTO
$1.09B
$40.8M 1.77%
831,312
+170,142
+26% +$8.64M
POOL icon
5
Pool Corp
POOL
$6.78B
$39.2M 1.71%
333,789
+68,076
+26% +$8.18M
IDTI
6
DELISTED
Integrated Device Technology I
IDTI
$39M 1.7%
1,513,457
+133,664
+10% +$3.25M
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.81B
$33.9M 1.48%
447,849
+95,990
+27% +$6.71M
LCII icon
8
LCI Industries
LCII
$2.46B
$30.8M 1.34%
300,416
+89,189
+42% +$8.56M
ACHC icon
9
Acadia Healthcare
ACHC
$2.71B
$30.2M 1.31%
+610,592
New +$27M
EFOR
10
Everforth Inc
EFOR
$1.11B
$29.9M 1.3%
551,382
+873
+0.2% +$44.8K
CEVA icon
11
CEVA Inc
CEVA
$921M
$28.4M 1.24%
625,877
+106,191
+20% +$4.36M
GMED icon
12
Globus Medical
GMED
$10.6B
$27.5M 1.19%
828,414
+888
+0.1% +$27.9K
ABCO
13
DELISTED
Advisory Board Co
ABCO
$27.2M 1.18%
528,636
+110,391
+26% +$5.53M
EFII
14
DELISTED
Electronics for Imaging
EFII
$27M 1.17%
569,125
+196,355
+53% +$9.37M
HCSG icon
15
Healthcare Services Group
HCSG
$1.57B
$26.7M 1.16%
569,378
+410
+0.1% +$18.9K
RAMP icon
16
LiveRamp
RAMP
$2.3B
$26.5M 1.15%
1,018,357
+293,963
+41% +$7.99M
PEGA icon
17
Pegasystems
PEGA
$4.91B
$26.3M 1.15%
903,146
+1,396
+0.2% +$36.8K
NKTR icon
18
Nektar Therapeutics
NKTR
$2.38B
$25.2M 1.1%
85,981
+17,638
+26% +$5.1M
TSEM icon
19
Tower Semiconductor
TSEM
$25.4B
$24.8M 1.08%
1,039,609
+130,717
+14% +$3.08M
OZK icon
20
Bank OZK
OZK
$5.56B
$23.3M 1.01%
497,114
+91,612
+23% +$4.36M
FN icon
21
Fabrinet
FN
$15.8B
$23.3M 1.01%
545,543
-1,774
-0.3% -$66.8K
CMPR icon
22
Cimpress
CMPR
$2.31B
$23.2M 1.01%
245,586
+50,727
+26% +$4.48M
EBS icon
23
Emergent Biosolutions
EBS
$365M
$22.7M 0.99%
669,617
+138,611
+26% +$4.28M
TXRH icon
24
Texas Roadhouse
TXRH
$13.6B
$22.5M 0.98%
441,262
+921
+0.2% +$44.5K
CY
25
DELISTED
Cypress Semiconductor
CY
$22.4M 0.98%
1,643,691
+344,870
+27% +$4.69M
1
2 3 4 5

Similar funds

GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
BP
BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return
CIM
Cambria Investment Management Manhattan Beach, California $1.79B AUM 28.1% 1-Year Est. Return
JCM
Jacobi Capital Management Pittston, Pennsylvania $1.79B AUM 17.94% 1-Year Est. Return
KPM
Kinetic Partners Management Miami, Florida $1.79B AUM 57.3% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Rice Hall James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Rice Hall James & Associates held 321 positions worth $2.3B, up 12% from $2.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rice Hall James & Associates deployed $141M of net new capital in Q2 2017, opening 26 new positions and adding to 135 existing holdings. Its largest new stake was Acadia Healthcare: 610,592 shares worth $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Advanced Energy, an estimated $6.38M trimmed.

  • Rice Hall James & Associates's largest Q2 2017 buy was Acadia Healthcare: 610,592 shares worth $30.2M.
  • Rice Hall James & Associates added most to Supernus Pharmaceuticals in Q2 2017, an estimated $9.54M increase.
  • Rice Hall James & Associates's biggest Q2 2017 reduction was Advanced Energy, cutting an estimated $6.38M.
  • Rice Hall James & Associates fully exited CEB Inc. in Q2 2017, selling an estimated $22.7M.
  • Rice Hall James & Associates's ten largest holdings make up 18% of its $2.3B portfolio in Q2 2017.
  • Rice Hall James & Associates opened 26 new positions and closed 32 in Q2 2017.
  • Rice Hall James & Associates's portfolio value rose 12% quarter-over-quarter to $2.3B.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.